Entity

Time filter

Source Type

San Diego, CA, United States

Pathway Genomics is a privately held personal genomics company based in San Diego, California. Using DNA genetic testing technologies, the company conducts services to generate personalized reports about an individual’s carrier status, drug response, propensity for the development of certain complex diseases, as well as ancestral history. The company provides these personal genetic reports to physicians and their patients. Pathway Genomics owns and operates a federally CLIA certified and California state-licensed on-site laboratory. According to its website, Pathway Genomics reports on a number of health conditions including Alzheimer's disease, type 1 and type 2 diabetes, hypertension, asthma, rheumatoid arthritis, cystic fibrosis and beta thalassaemia, as well as screens for drug responses for such medications as Plavix and warfarin . The company has registered its saliva collection kit with the U.S. Food and Drug Administration as a Class I 510 Exempt medical device. Wikipedia.


Patent
Pathway Genomics | Date: 2014-03-13

The present inventions relates to methods and assays to predict the response of an individual to an SSRI treatment and to a method to improve medical treatment of a disorder, which is responsive to treatment with a selective serotonin reuptake inhibitor (SSRI).


In accordance with the present invention, there are provided health and wellness management methods which generate an action plan set of recommendations by taking into account a wide variety of inputs, including subject-specific information and globally applicable information. Also provided herewith are systems for the practice of the above-described methods.


The present inventions relates to methods and assays to predict the response of an individual to psychiatric treatment and to a method to improve medical treatment of a disorder, which responsive to treatment with a psychiatric treatment.


Patent
Pathway Genomics | Date: 2013-06-13

The present inventions relates to methods and assays to predict the response of an individual to an SSRI treatment and to a method to improve medical treatment of a disorder, which is responsive to treatment with a selective serotonin reuptake inhibitor (SSRI).


Patent
Pathway Genomics | Date: 2014-03-12

The present invention relates to systems and methods for predicting an individuals likely response to a pain medication comprising genotyping genetic variations in an individual to determine the individuals propensity for metabolizing a pain medication and likely response to a medication, and preferably diverse reactions to a medication. In particular, the invention comprises analyzing a biological sample provided by an individual, typically a patient or an individual diagnosed with a particular disorder, determining the individuals likely response to a particular treatment, more specifically a pain medication, and thereafter displaying, or further, recommending a plan of action or inaction. In particular, the present invention provides a grading method and system to profile an individuals response to one or more pain medication.

Discover hidden collaborations